BR9805041A - Composição útil no diagnóstico precoce de leishmanìase visceral e processo para preparação da mesma - Google Patents

Composição útil no diagnóstico precoce de leishmanìase visceral e processo para preparação da mesma

Info

Publication number
BR9805041A
BR9805041A BR9805041-9A BR9805041A BR9805041A BR 9805041 A BR9805041 A BR 9805041A BR 9805041 A BR9805041 A BR 9805041A BR 9805041 A BR9805041 A BR 9805041A
Authority
BR
Brazil
Prior art keywords
early diagnosis
visceral leishmaniasis
preparing
useful composition
useful
Prior art date
Application number
BR9805041-9A
Other languages
English (en)
Portuguese (pt)
Inventor
Girish Kumar Jain
Suman Tiwari
Suman Gupta
Jagdish Chandra Katiyar
Original Assignee
Council Scient Ind Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council Scient Ind Res filed Critical Council Scient Ind Res
Publication of BR9805041A publication Critical patent/BR9805041A/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR9805041-9A 1997-12-08 1998-11-25 Composição útil no diagnóstico precoce de leishmanìase visceral e processo para preparação da mesma BR9805041A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3518DE1997 IN187039B (OSRAM) 1997-12-08 1997-12-08

Publications (1)

Publication Number Publication Date
BR9805041A true BR9805041A (pt) 2001-03-20

Family

ID=11092804

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9805041-9A BR9805041A (pt) 1997-12-08 1998-11-25 Composição útil no diagnóstico precoce de leishmanìase visceral e processo para preparação da mesma

Country Status (3)

Country Link
US (1) US6423529B1 (OSRAM)
BR (1) BR9805041A (OSRAM)
IN (1) IN187039B (OSRAM)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU120988A (en) * 1988-06-23 1990-06-30 Lek Tovarna Farmacevtskih Process for preparing new dispersion pills of cimetidine
EP0495187B1 (en) * 1991-01-15 1997-01-22 Hemosphere, Inc. Protein nanomatrixes and method of production
AU2309692A (en) 1991-07-03 1993-02-11 Cryolife, Inc. Method for stabilization of biomaterials
BR9302386A (pt) 1993-06-17 1995-01-17 Univ Rio De Janeiro Composição contendo frações de células de leishmania, denominadas antígeno FML "fucose mannose ligand" ou "ligante de fucose-manose", uso de antígeno FML e de suas subfrações e componentes para as aplicações em imunodiagnóstico específico da leishmaniose visceral humana e animal, para aplicações em vacinação, tratamento ou imunoterapia contra a leishmaniose visceral humana e canina
AU5543294A (en) 1993-10-29 1995-05-22 Pharmos Corp. Submicron emulsions as vaccine adjuvants
EP0997734B1 (en) 1998-10-29 2006-09-27 Council of Scientific and Industrial Research Composition useful for the early diagnosis of visceral leishmaniasis and a process for preparing the same

Also Published As

Publication number Publication date
IN187039B (OSRAM) 2001-12-29
US6423529B1 (en) 2002-07-23

Similar Documents

Publication Publication Date Title
BG103335A (en) Application of fumaric acid derivatives
BR0209709A (pt) Composições hipotensivas de lipìdio e timolol e métodos de uso das mesmas
CA2259163A1 (en) Nt-3 and bdnf analogs having improved circulating life and/or absorption
EA200400067A1 (ru) Конъюгаты гксф
ES2136668T3 (es) Fosfato calcico como precursor de la hidroxiapatita y procedimiento para su preparacion y utilizacion.
CA2286098A1 (en) Compositions comprising conjugates of stable, active, human ob protein with antibody fc chain and methods
BR0305074A (pt) Composições cosméticas com alta afinidade
TR200101725T2 (tr) Enteral bileşimler için lif karışımı.
BR9808965A (pt) Composições comestìveis inluindo gel particulado
BR9815445A (pt) Complexos lipìdicos e lipossomas de complexos de platina altamente insolúveis
DE69002767D1 (de) Fluor- und phosphorhaltige amphiphilische molekuele mit oberflaechenaktiven eigenschaften.
BR9814571A (pt) Campo cirúrgico e kit de campo cirúrgico
ES2165391T3 (es) Esteres del acido metilfosfonico, procedimiento para su preparacion y su empleo.
EA200000765A1 (ru) Получение липидной смеси и фосфолипидная суспензия, содержащая липидную смесь
EA199901013A1 (ru) Гели пролонгированного действия
GR3018691T3 (en) Amino acids, peptides or derivatives thereof coupled to fats
EP1762574A3 (en) Chemical modification of proteins to improve biocompatibility and bioactivity
EA199700032A1 (ru) Дезинфицирующий состав "велтолен"
EA199901113A1 (ru) Карбоксамиды в качестве агонистов 5-ht1f
KR960007539A (ko) 오르토-치환된 벤조산 유도체
CA2218145A1 (en) Method of treating dilated cardiomyopathy
BR9805041A (pt) Composição útil no diagnóstico precoce de leishmanìase visceral e processo para preparação da mesma
CO5150178A1 (es) Bromohidrato de eletriptan monohidrato y procedimiento para su preparacion
DK0906272T3 (da) Peptider
ATE356209T1 (de) Mutanten des thyroid-stimulierenden hormons

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: O DEPOSITANTE DEIXOU DE APRESENTAR MANIFESTACAO SOBRE O PARECER NEGATIVO, ASSIM, DE ACORDO COM O ART. 36 DA LPI (LEI 9279/96) 2O, O PEDIDO VOLTA A EXAME SENDO CONSIDERADO NAO PATENTEAVEL PELAS RAZOES EXPOSTAS NO PARECER TECNICO ANTERIOR.